Ameriprise’s Veoneer, Inc. VNE Stock Holding History

Ameriprise’s Portfolio VNE Stock Details VNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-253,280	Closed	-$9.36M	–	4061
2022 Q1	$9.36M	Buy	253,280 +210,168	+487%	+$7.48M	﹤0.01%	1965
2021 Q4	$1.53M	Buy	43,112 +17,756	+70%	+$628K	﹤0.01%	3061
2021 Q3	$864K	Buy	+25,356	New	+$806K	﹤0.01%	3223
2019 Q2	–	Sell	-15,914	Closed	-$364K	–	3815
2019 Q1	$364K	Sell	15,914 -120	-0.7%	-$3.33K	﹤0.01%	3384
2018 Q4	$377K	Sell	16,034 -74	-0.5%	-$2.6K	﹤0.01%	3286
2018 Q3	$887K	Buy	+16,108	New	+$828K	﹤0.01%	3118

Other funds holding VNE

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Ameriprise's VNE Position: Q2 2022 in Review

Ameriprise sold out of Veoneer, Inc. (VNE) in Q2 2022, closing a stake of 253,280 shares — an estimated $9.36M sold.

Ameriprise first reported a position in VNE in Q3 2018 and held it in 6 quarters. The position peaked at $9.36M in Q1 2022. 1 fund tracked by Wall St. Rank holds VNE as of Q2 2022.

Ameriprise reported no remaining Veoneer, Inc. position as of Q2 2022 after selling out during the quarter.
Ameriprise sold 253,280 Veoneer, Inc. shares in Q2 2022, an estimated $9.36M.
Ameriprise first reported a position in Veoneer, Inc. in Q3 2018 and held it in 6 quarters.
Ameriprise's Veoneer, Inc. position peaked at $9.36M in Q1 2022.
1 fund tracked by Wall St. Rank held Veoneer, Inc. as of Q2 2022.

Based on Ameriprise's 13F filing for Q2 2022, filed 15 Aug 2022.